Singapore to ease Covid measures, reopen borders and drop outdoor mask mandate

Singapore to ease Covid measures, reopen borders and drop outdoor mask mandate


Office workers walk out for lunch break at Raffles Place financial business district in Singapore on January 4, 2022.

Roslan Rahman | AFP | Getty Images

SINGAPORE — Singapore will ease most of its Covid restrictions including outdoor mask mandates from March 29, Prime Minister Lee Hsien Loong announced on Thursday.

Limits on social gatherings will be doubled from five to 10, more employees can return to office and capacity limits for large events will be increased, Lee said in a national address.

Masks will still be needed indoors, and safe distancing of 1 meter between groups in mask-off settings will still be required.

Throughout the pandemic, Singapore has been more consistent and strict about measures such as mask mandates and traceability than most of the rest of the world.

Lee also said testing and quarantine requirements for travelers will be “drastically streamlined” and will let Singaporeans travel abroad more easily — “almost like before Covid-19.”

“Resume more normal lives, enjoy larger gatherings of family and friends, go outdoors without masks, or reunite with loved ones abroad,” Lee said. “But do not throw all caution to the wind.”

He called on people to comply with the relaxed rules and test regularly.

Border measures

On travel restrictions and measures, all fully vaccinated travelers will no longer require tests upon arrival in Singapore from April 1, Transport Minister S Iswaran said at a press briefing.

Pre-departure tests will still be needed.

The peak of the omicron wave in Singapore appears to have passed. New daily cases stood at 8,940 on Wednesday, down from a record 26,032 infections on Feb. 22.

As of Tuesday, 92% of the population has received two shots under the national vaccination program, while 71% have received boosters.

The majority of people infected in Singapore have mild or no symptoms. Around 0.3% required oxygen supplementation over the last 28 days, and 0.04% were in the intensive care unit.



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More